title: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
mesh_terms: D026683:Advisory Committees; D000572:American Heart Association / Q000458:organization & administration; D005544:Forecasting; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D033183:Interdisciplinary Communication; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D012084:Renin-Angiotensin System / Q000187:drug effects; D012955:Societies, Medical / Q000458:organization & administration; D013318:Stroke Volume / Q000187:drug effects*; D014481:United States
keywords: AHA Scientific Statements; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides